DARLA PEARCE: Open Payments
NPI 1689761215 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 64 payments from 22 companies in 2025. Trend: 2023 $1,587 · 2024 $2,169 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $322 |
| Axsome Therapeutics, Inc. | 11 | $245 |
| PFIZER INC. | 8 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Novo Nordisk Inc | 6 | $110 |
| Lundbeck LLC | 5 | $105 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Alkermes, Inc. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: FARXIGA, Auvelity, REXULTI, NURTEC ODT, CAPLYTA, Jornay PM, ARISTADA, AIRSUPRA.
Industry payments across CO — which companies pay providers there.
